Erika Bourguet

Erika Bourguet

Auto-generated profile, based on publicly available information

Erika Bourguet

Université de Reims Champagne-Ardenne, Institut de Chimie Moléculaire de Reims (ICMR), CNRS UMR 7312, 51097 Reims, France

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
GMGautier Moroy
Gautier Moroy
AAAlain J.P. Alix
Alain J.P. Alix
JSJanos Sapi
Janos Sapi
WHWilliam Hornebeck
William Hornebeck
EBErika Bourguet
Erika Bourguet
Human neutrophil elastase (HNE), a main actor in the development of chronic obstructive pulmonary diseases, has been recently involved in non-small cell lung cancer progression. It can act at several levels (i) intracellularly, cleaving for instance the adaptor molecule insulin receptor substrate-1 (IRS-1) (ii) at the cell surface, hydrolyzing receptors as CD40 (iii) in the extracellular space, generating elastin fragments i.e. morphoelastokines which potently stimulate cancer cell invasiveness and angiogenesis. Since decades, researchers identified natural compounds and/or synthesized agents which antagonize HNE activity that will be described in this review article. Some of these compounds might be of value as therapeutic agents in lung cancer. However, it is now widely accepted that lung tumor invasion and metastasis involve proteolytic cascades. Accordingly, we will here mainly focus our attention to natural substances able to display a dual inhibitory capacity (i.e. lipids and derivatives, phenolics) towards HNE and matrix metalloproteinases (MMPs), particularly MMP-2. To that purpose, we recently synthesize substances named “LipoGalardin” (Moroy G. et al., Biochem. Pharmacol., 2011, 81(5), 626-635) exhibiting such inhibitory bifunctionality. At last, we will propose an original synthetic scheme for designing a potent biheaded HNE/MMP-2 inhibitor.

1 September 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GLGwennaël LeDour
Gwennaël LeDour
GMGautier Moroy
Gautier Moroy
MRMatthieu Rouffet
Matthieu Rouffet
EBErika Bourguet
Erika Bourguet
DGDominique Guillaume
Dominique Guillaume
JSJanos Sapi
Janos Sapi

16 February 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EBErika Bourguet
Erika Bourguet
SFSylwia Figurska
Sylwia Figurska
MFManuela Maria Fra̧cZek
Manuela Maria Fra̧cZek

3 August 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EBErika Bourguet
Erika Bourguet
KOKatarzyna Ozdarska
Katarzyna Ozdarska
GMGautier Moroy
Gautier Moroy
JJJérôme Jeanblanc
Jérôme Jeanblanc
Mickael NaassilaMickael Naassila
Mickael Naassila

8 September 2001 in Organic Letters
Verified
Journal Article
Closed access
EBErika Bourguet
Erika Bourguet
JBJean-Louis Baneres
Jean-Louis Baneres
JGJean-Pierre Girard
Jean-Pierre Girard
JPJoseph Parello
Joseph Parello
JVJean-Pierre Vidal
Jean-Pierre Vidal
JDJean-Paul Declercq
Jean-Paul Declercq

1 July 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GMGautier Moroy
Gautier Moroy
CDClément Denhez
Clément Denhez
HMHaquima El Mourabit
Haquima El Mourabit
ATAlix Toribio
Alix Toribio
ADAlexandra Dassonville
Alexandra Dassonville
EBErika Bourguet
Erika Bourguet